Table 5.
Total Motility (%) | Progressive Motility (%) | Non-Progressive (%) | Immobility (%) | |
---|---|---|---|---|
7-day treatment | ||||
Control | 60.29 ± 5.78 c | 62.02 ± 5.46 c | 30.34 ± 3.57 a | 35.61 ± 1.91 a |
10 mg/kg | 40.71 ± 3.35 b | 34.44 ± 3.97 b | 44.36 ± 8.60 b | 56.24 ± 2.53 b |
50 mg/kg | 20.23 ± 1.69 a | 9.20 ± 0.69 a | 46.19 ± 4.49 b | 66.49 ± 4.10 c |
28-day treatment | ||||
Control | 57.16 ± 4.49 c | 62.76 ± 5.33 c | 44.29 ± 9.12 a | 29.99 ± 5.24 a |
10 mg/kg | 34.13 ± 0.57 b | 25.10 ± 6.52 b | 52.76 ± 4.71 b | 63.43 ± 2.90 b |
50 mg/kg | 9.65 ± 0.53 a | 3.88 ± 1.33 a | 59.05 ± 0.51 b | 76.81 ± 4.31 c |
Data expressed as mean ± standard deviation of triplicate determination. Data followed by different superscript alphabet along the same column are significantly different (p < 0.05). The high significant levels of the parameters were in the order of a < b < c. Data with superscript alphabet “a” are significantly lower than data with superscript alphabet “b” while data with superscript “b” are lower than data with superscript alphabet “c” at p < 0.05.